• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹直肌和骨骼肌参数与血管内动脉瘤修复术后生存的关系:系统评价和荟萃分析。

The relationship between pre-operative psoas and skeletal muscle parameters and survival following endovascular aneurysm repair: a systematic review and meta-analysis.

机构信息

Academic Department of Surgery, University of Glasgow, New Lister Building, Glasgow Royal Infirmary, Glasgow, G4 0SF, UK.

出版信息

Sci Rep. 2022 Oct 5;12(1):16663. doi: 10.1038/s41598-022-20490-3.

DOI:10.1038/s41598-022-20490-3
PMID:36198699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9534993/
Abstract

Sarcopenia is characterised by chronically reduced skeletal muscle volume and function, and is determined radiologically by psoas and skeletal muscle measurement. The present systematic review and meta-analysis aims to examine the relationship between pre-operative CT-derived psoas and skeletal muscle parameters and outcomes in patients undergoing EVAR and F/B-EVAR for aortic aneurysm. The MEDLINE database was interrogated for studies investigating the effect of pre-operative CT-diagnosed sarcopenia on outcomes following EVAR and F/B-EVAR. The systematic review was carried out in accordance with PRISMA guidelines. The primary outcome was overall mortality. RevMan 5.4.1 was used to perform meta-analysis. PROSPERO Database Registration Number: CRD42021273085. Ten relevant studies were identified, one reporting skeletal muscle parameters, and the remaining nine reporting psoas muscle parameters, which were used for meta-analysis. There were a total of 2563 patients included (2062 EVAR, 501 F/B-EVAR), with mean follow-up ranging from 25 to 101 months. 836 patients (33%) were defined as radiologically sarcopenic. In all studies, the combined HR for all-cause mortality in sarcopenic versus non-sarcopenic patients was 2.61 (1.67-4.08), p < .001. Two studies reported outcomes on patients undergoing F/B-EVAR; the combined HR for all-cause mortality in sarcopenic versus non-sarcopenic patients was 3.08 (1.66-5.71), p = .004. Radiological sarcopenia defined by psoas or skeletal muscle parameters was associated with inferior survival in patients undergoing both EVAR and F/B-EVAR. Current evidence is limited by heterogeneity in assessment of body composition and lack of a consensus definition of radiological sarcopenia.

摘要

肌肉减少症的特征是骨骼肌体积和功能长期减少,并通过腰椎旁肌和骨骼肌测量进行放射学诊断。本系统评价和荟萃分析旨在研究接受腹主动脉瘤腔内修复术(EVAR)和杂交腔内修复术(F/B-EVAR)的患者术前 CT 腰椎旁肌和骨骼肌参数与结局的关系。通过 MEDLINE 数据库检索研究 EVAR 和 F/B-EVAR 后术前 CT 诊断的肌肉减少症对结局影响的研究。系统评价按照 PRISMA 指南进行。主要结局是总死亡率。RevMan 5.4.1 用于进行荟萃分析。PROSPERO 数据库注册号:CRD42021273085。确定了 10 项相关研究,其中 1 项报告了骨骼肌参数,其余 9 项报告了腰椎旁肌参数,这些参数用于荟萃分析。共纳入 2563 例患者(2062 例 EVAR,501 例 F/B-EVAR),平均随访时间为 25 至 101 个月。836 例(33%)患者被诊断为放射学肌肉减少症。在所有研究中,肌肉减少症患者与非肌肉减少症患者的全因死亡率的合并 HR 为 2.61(1.67-4.08),p<0.001。有 2 项研究报告了 F/B-EVAR 患者的结局;肌肉减少症患者与非肌肉减少症患者的全因死亡率的合并 HR 为 3.08(1.66-5.71),p=0.004。通过腰椎旁肌或骨骼肌参数定义的放射学肌肉减少症与接受 EVAR 和 F/B-EVAR 的患者的生存预后不良相关。目前的证据受到评估身体成分的异质性和缺乏放射学肌肉减少症共识定义的限制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/5700db99ae25/41598_2022_20490_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/eee55b3ad5a0/41598_2022_20490_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/1b5edba5b200/41598_2022_20490_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/b7ac93b9582d/41598_2022_20490_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/5700db99ae25/41598_2022_20490_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/eee55b3ad5a0/41598_2022_20490_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/1b5edba5b200/41598_2022_20490_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/b7ac93b9582d/41598_2022_20490_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e2/9534993/5700db99ae25/41598_2022_20490_Fig4_HTML.jpg

相似文献

1
The relationship between pre-operative psoas and skeletal muscle parameters and survival following endovascular aneurysm repair: a systematic review and meta-analysis.腹直肌和骨骼肌参数与血管内动脉瘤修复术后生存的关系:系统评价和荟萃分析。
Sci Rep. 2022 Oct 5;12(1):16663. doi: 10.1038/s41598-022-20490-3.
2
Scoping review of radiologic assessment and prognostic impact of skeletal muscle sarcopenia in patients undergoing endovascular repair for aortic disease.主动脉疾病血管内修复患者骨骼肌减少症的影像学评估及预后影响的范围回顾。
J Vasc Surg. 2022 Nov;76(5):1407-1416. doi: 10.1016/j.jvs.2022.05.005. Epub 2022 Jun 3.
3
Sarcopenia is a Prognostic Biomarker for Long-Term Survival after Endovascular Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis.肌肉减少症是血管内主动脉瘤修复后长期生存的预后生物标志物:系统评价和荟萃分析。
Ann Vasc Surg. 2022 Jul;83:358-368. doi: 10.1016/j.avsg.2022.02.025. Epub 2022 Mar 12.
4
Effect of Low Skeletal Muscle Mass on Post-operative Survival of Patients With Abdominal Aortic Aneurysm: A Prognostic Factor Review and Meta-Analysis of Time-to-Event Data.低骨骼肌质量对腹主动脉瘤患者术后生存的影响:预后因素回顾和时间事件数据的荟萃分析。
Eur J Vasc Endovasc Surg. 2019 Aug;58(2):190-198. doi: 10.1016/j.ejvs.2019.03.020. Epub 2019 Jun 13.
5
Sarcopenia predicts mortality and adverse outcomes after endovascular aneurysm repair and can be used to risk stratify patients.肌少症预测血管内动脉瘤修复术后的死亡率和不良结局,可用于对患者进行风险分层。
J Vasc Surg. 2019 Nov;70(5):1576-1584. doi: 10.1016/j.jvs.2018.12.038. Epub 2019 Mar 7.
6
Low total psoas area as scored in the clinic setting independently predicts midterm mortality after endovascular aneurysm repair in male patients.在临床环境中评分较低的总腰大肌面积可独立预测男性患者血管内动脉瘤修复后的中期死亡率。
J Vasc Surg. 2018 Feb;67(2):460-467. doi: 10.1016/j.jvs.2017.06.085. Epub 2017 Aug 23.
7
Association Between Psoas Muscle Sarcopenia and Long-Term Survival Following Elective Endovascular Aortic Repair.腰大肌肌少症与择期血管内主动脉修复术后长期生存的关系。
J Surg Res. 2022 Dec;280:459-468. doi: 10.1016/j.jss.2022.07.006. Epub 2022 Sep 1.
8
Statin use, development of sarcopenia, and long-term survival after endovascular aortic repair.他汀类药物的使用、肌肉减少症的发展与血管内主动脉修复术后的长期生存。
J Vasc Surg. 2021 Nov;74(5):1651-1658.e1. doi: 10.1016/j.jvs.2021.04.054. Epub 2021 May 19.
9
The association between sarcopenia and adverse outcomes after complex endovascular aortic repair.肌肉减少症与复杂血管内主动脉修复术后不良结局的关系。
J Cardiovasc Surg (Torino). 2024 Jun;65(3):256-264. doi: 10.23736/S0021-9509.23.12821-7. Epub 2023 Nov 21.
10
Impact of Total Psoas Area and Lean Muscular Area on Mortality after Endovascular Aortic Aneurysm Repair.总腰大肌面积和瘦肌肉面积对血管内主动脉瘤修复后死亡率的影响。
Ann Vasc Surg. 2021 Apr;72:479-487. doi: 10.1016/j.avsg.2020.09.004. Epub 2020 Sep 16.

引用本文的文献

1
Longitudinal association between statins and changes in CT-derived body composition in patients with abdominal aortic aneurysm.他汀类药物与腹主动脉瘤患者CT衍生身体成分变化之间的纵向关联。
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2). doi: 10.1002/jcsm.13565.
2
Relationship between CT-derived cervical muscle mass and quality, systemic inflammation, and survival in symptomatic patients undergoing carotid endarterectomy.颈动脉内膜切除术症状患者 CT 检测的颈肌量和质量、全身炎症与生存的关系。
BJS Open. 2024 Sep 3;8(5). doi: 10.1093/bjsopen/zrae114.
3
Evaluation of the prognostic value of computed tomography-derived body composition in patients undergoing endovascular aneurysm repair.

本文引用的文献

1
Sarcopenia is a Prognostic Biomarker for Long-Term Survival after Endovascular Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis.肌肉减少症是血管内主动脉瘤修复后长期生存的预后生物标志物:系统评价和荟萃分析。
Ann Vasc Surg. 2022 Jul;83:358-368. doi: 10.1016/j.avsg.2022.02.025. Epub 2022 Mar 12.
2
Preoperative sarcopenia and malnutrition are correlated with poor long-term survival after endovascular abdominal aortic aneurysm repair.术前肌少症和营养不良与腹主动脉瘤腔内修复术后长期生存不良相关。
Surg Today. 2022 Jan;52(1):98-105. doi: 10.1007/s00595-021-02362-x. Epub 2021 Sep 3.
3
The natural history of large abdominal aortic aneurysms in patients without timely repair.
评估计算机断层扫描(CT)衍生的体成分分析在血管内动脉瘤修复患者中的预后价值。
J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1836-1847. doi: 10.1002/jcsm.13262. Epub 2023 May 23.
未及时修复的大型腹主动脉瘤患者的自然病史。
J Vasc Surg. 2022 Jan;75(1):109-117. doi: 10.1016/j.jvs.2021.07.125. Epub 2021 Jul 26.
4
Association between Low Muscle Mass and Inflammatory Cytokines.肌肉减少症与炎症细胞因子的关系。
Biomed Res Int. 2021 Apr 27;2021:5572742. doi: 10.1155/2021/5572742. eCollection 2021.
5
Adverse Outcomes after Advanced EVAR in Patients with Sarcopaenia.肌肉减少症患者接受先进腹主动脉瘤腔内修复术后的不良结局。
Cardiovasc Intervent Radiol. 2021 Mar;44(3):376-383. doi: 10.1007/s00270-020-02721-0. Epub 2021 Jan 3.
6
Postimplantation syndrome in endovascular aortic aneurysm repair - a systematic review.血管内主动脉瘤修复术后植入综合征 - 系统评价。
Vasa. 2021 Apr;50(3):174-185. doi: 10.1024/0301-1526/a000913. Epub 2020 Nov 3.
7
Computed tomography-derived body composition analysis in patients with advanced cancer: clinical utility and future research.计算机断层扫描衍生的体成分分析在晚期癌症患者中的应用:临床效用和未来研究。
Curr Opin Support Palliat Care. 2020 Dec;14(4):309-315. doi: 10.1097/SPC.0000000000000529.
8
Sarcopenia Aneurysm Scoring System Predicts Early and Midterm Mortality After Endovascular Repair for Abdominal Aortic Aneurysm.骨骼肌减少症动脉瘤评分系统预测腹主动脉瘤血管内修复术后早期和中期死亡率。
Ann Surg. 2022 Oct 1;276(4):e247-e254. doi: 10.1097/SLA.0000000000004230. Epub 2020 Sep 29.
9
Impact of Total Psoas Area and Lean Muscular Area on Mortality after Endovascular Aortic Aneurysm Repair.总腰大肌面积和瘦肌肉面积对血管内主动脉瘤修复后死亡率的影响。
Ann Vasc Surg. 2021 Apr;72:479-487. doi: 10.1016/j.avsg.2020.09.004. Epub 2020 Sep 16.
10
Pre-operative Psoas Muscle Size Combined With Radiodensity Predicts Mid-Term Survival and Quality of Life After Fenestrated-Branched Endovascular Aortic Repair.术前腰大肌大小结合放射密度预测开窗分支血管腔内修复术后中期生存和生活质量。
Eur J Vasc Endovasc Surg. 2020 Jan;59(1):31-39. doi: 10.1016/j.ejvs.2019.06.021. Epub 2019 Nov 9.